Mateos, M., Rodríguez-Otero, P., Usmani, S., Kumar, S., Ye, J., Atrash, S., Magen, H., Quach, H., Chu, M., Trudel, S., Richter, J., Chuah, H., Gatt, M., Medvedova, E., Raza, S., Yoon, D., Ishida, T., Matous, J., Rosiñol, L., Onodera, K., Maffucci, C., Scott, E., Heuck, C., Zhang, J., Henninger, T., O’Rourke, L., Thakkar, P., Festa, M., Huang, L., Zhou, J., Takamoto, M., Pei, L., Lu, J., Au, N., Krevvata, M. and Cohen, Y. (2026) “P40 | EFFICACY AND SAFETY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE: UPDATED PHASE 2 RESULTS FROM THE RedirecTT-1 STUDY WITH EXTENDED FOLLOW-UP”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14055.